Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer‐masked, three‐centre study
AUTOR(ES)
Konstas, A G P
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1955604Documentos Relacionados
- Atenolol eye drops in glaucoma: a double-masked, controlled study.
- A blind randomised cross-over trial comparing metipranolol 0.3% with timolol 0.25% in open-angle glaucoma: a pilot study.
- Deprivation and late presentation of glaucoma: case-control study
- 5-Nitro-N 4,N 6-diphenylpyrimidine-4,6-diamine: polarized molecules linked into π-stacked chains via three-centre C—H⋯(O)2 hydrogen bonds
- Latanoprost--a promising new glaucoma drug.